Lord’s Mark Industries Secures UK MHRA Registration for In Vitro Diagnostics Portfolio
Lords Mark Industries Ltd · Others (Uncategorized) · 05 Oct 2026, 2:10 pm
Lord’s Mark Industries Secures UK MHRA Registration for In Vitro Diagnostics Portfolio Lord’s Mark Industries Limited received UK MHRA registration on 24th Sep'26 for its in vitro diagnostics (IVD) portfolio, covering haematological cell analysers, clinical chemistry analysers, buffered diluents, and cleaning agents. Commercial sales in the UK are slated to begin in Dec'26, two months ahead of schedule, with further expansion targeted across UK-allied markets. Additionally, the company plans to commence UK pathology laboratory operations in Jan'27, transitioning toward an integrated healthcare delivery model following its recent registration of the AI-powered Renalyx haemodialysis system.
Original exchange filing (PDF)
More announcements from Lords Mark Industries Ltd
- Investor Presentation H1 · 18 Nov 2026
- Investor Meet on 19th Nov 2026 · 16 Nov 2026
- Revised Outcome of BM held on 14 Nov 2026 · 15 Nov 2026
- Revised financials for September 2026 · 15 Nov 2026
- Outcome of Board Meeting held on 14.11.2026 · 14 Nov 2026
- September 2026 results · 14 Nov 2026
- Lords Mark Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Board Meeting intimation .... · 14 Nov 2026
- Dr. Sachidanand Upadhyay , MD has featured in TIME magazine for third consecutive years . · 03 Nov 2026
